Key result
123I-MIBG scintigraphy fails to predict appropriate ICD interventions, death, or heart transplantation.
Why the study?
Current ICD qualification criteria rely on imperfect parameters, so the study assessed whether cardiac adrenergic system scintigraphy could improve patient selection in post-infarction HFrEF.
Does [123I]MIBG cardiac adrenergic system scintigraphy predict appropriate ICD interventions or death/heart transplantation in post-infarction HFrEF patients?
Cohort (n=85)
No
Does [123I]MIBG cardiac adrenergic system scintigraphy predict appropriate ICD interventions or death/heart transplantation in post-infarction HFrEF patients?
[123I]MIBG scintigraphy parameters did not effectively predict appropriate ICD interventions or mortality in post-infarction HFrEF patients, whereas clinical factors like age and LVEF were significant predictors.
MIBG scintigraphy should not guide ICD decisions in post-MI HFrEF; leaves open whether refined parameters add value beyond LVEF.
Background: Post-infarction heart failure with reduced ejection fraction (HFrEF) patients often face persistent risks of sudden cardiac arrest leading to sudden cardiac death. While implanting a cardioverter-defibrillator (ICD) can enhance prognosis, complications and costs limit its widespread use. Current patient qualification criteria, relying on imperfect parameters, require refinement. The impairment of the cardiac adrenergic system in heart failure is associated with ventricular arrhythmias. The goal of the study was to assess the utility of cardiac adrenergic system scintigraphy in qualifying patients for ICD placement. Methods: In this prospective study of 85 post-infarction HFrEF patients at a single center, clinical assessments, laboratory tests, echocardiography, [123I]MIBG scintigraphy, and ICD implantation were performed. Scintigraphy involved planar chest images and evaluating the heart-to-mediastinum ratio (H/M) and washout rate (WO). SPECT imaging assessed [123I]MIBG uptake in 17 left ventricular segments to calculate the summed difference score (SDS). Results: During a median of 4-year follow-up, 22% of patients experienced appropriate ICD interventions, and 25% of patients died or underwent heart transplantation. The mean values of analyzed parameters did not significantly differ between groups. In the univariate analysis, younger age and moderately impaired left ventricular ejection fraction (LVEF) were correlated with more frequent ICD interventions. In comparison, older age and elevated NT-proBNP levels were associated with death or heart transplantation. Additionally, the univariate analysis identified SDS-15′ as a prognostic factor for death/heart transplant. The multivariate analysis identified predictors for ICD interventions, including younger age, an EF of 30% or greater, and a larger left ventricular end-diastolic diameter. In contrast, older age and an LVEF of less than 25% were significant predictors of death or heart transplantation. Conclusions: Scintigraphic parameters did not effectively predict ICD interventions or death/heart transplantation, though the summed difference score demonstrated potential as a prognostic factor. Younger age with moderately impaired EF correlated with frequent ICD interventions, while in older age, EF < 25% predicted death or transplantation. Further investigation is needed for patients with borderline EF values.
No takes yet. Share an insight, caveat, or question.
Teresińska et al. (2024) conducted a cohort in Post-infarction heart failure with reduced ejection fraction (HFrEF) (n=85). [123I]MIBG cardiac adrenergic system scintigraphy and baseline characteristics was evaluated on Appropriate ICD interventions and death or heart transplantation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: